Vaccines: Where Inertia, Innovation, and Revolution Create Value, Simultaneously and Quietly

This chapter focuses on the dynamics of innovation in the field of vaccines. Preventive vaccines differ substantially from therapeutic pharmaceuticals and require a specific approach to innovation all along their value chain to address their distinctive challenges. We analyze the fundamentals and the dynamics of the vaccine market and industry, to highlight these challenges. We next describe new developments and where innovation is needed along the key dimensions of the value chain of the vaccine market. We conclude with some assumptions on innovation trends and sources.

For Read More →
http://onlinelibrary.wiley.com/doi/10.1002/9783527693405.ch13/summary

MRGN Advisors

MRGN Advisors 
Rue du Mont-Blanc 4    
Case postale 2067    
CH – 1211 Genèva 1 
Switzerland

Archives